Report Detail

Request for Sample of this report

Pharma & Healthcare Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Supply, Demand and Key Producers, 2026-2032

  • RnM4666803
    • |
  • 22 January, 2026
    • |
  • Global
    • |
  • 107 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size is expected to reach $ 3813 million by 2032, rising at a market growth of 10.4% CAGR during the forecast period (2026-2032).
Irritable bowel syndrome (IBS) is a common disorder that affects the large intestine. Signs and symptoms include cramping, abdominal pain, bloating, gas, and diarrhea or constipation, or both. IBS is a chronic condition that need to manage long term.
IBS that causes increased diarrhea is often called IBS-D. Diarrhea predominant irritable bowel syndrome (IBS-D) is a subtype of IBS in which a person experiences frequent episodes of diarrhea with accompanying abdominal pain. Like IBS, IBS-D is a functional gastrointestinal disorder (FGD) in that there is no visible disease, inflammation, or injury to account for its symptoms. It is estimated that approximately a third of people who have IBS experience the disorder with diarrhea as the predominant bowel habit.
In this report, we study the drugs for diarrhea predominant irritable bowel syndrome (IBS-D).
North America is the largest consumption place of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs, followed by Europe. The two account for more than 80% of the consumer market in together. The most used IBS-D drug is XIFAXAN, accounting for more than 60% of the market share, followed by Viberzi and Lotronex. IBS-D drugs are widely sold through hospital pharmacies and retail pharmacies.
This report studies the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs total production and demand, 2021-2032, (K Units)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs total production value, 2021-2032, (USD Million)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs domestic production, consumption, key domestic manufacturers and share
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs production by Sales Channel, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bausch Health, Allergan, Sebela Pharmaceuticals, Astellas Pharmaceuticals, Amneal Pharms, Pharscin Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Sales Channel. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, Segmentation by Type:
XIFAXAN
Viberzi
Lotronex
Other
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, Segmentation by Sales Channel:
Hospitals Pharmacy
Retail Pharmacy
Other
Companies Profiled:
Bausch Health
Allergan
Sebela Pharmaceuticals
Astellas Pharmaceuticals
Amneal Pharms
Pharscin Pharma
Key Questions Answered:
1. How big is the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market?
2. What is the demand of the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market?
3. What is the year over year growth of the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market?
4. What is the production and production value of the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market?
5. Who are the key producers in the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market?
6. What are the growth factors driving the market demand?


1 Supply Summary

  • 1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Introduction
  • 1.2 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Supply & Forecast
    • 1.2.1 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Value (2021 & 2025 & 2032)
    • 1.2.2 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (2021-2032)
    • 1.2.3 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Pricing Trends (2021-2032)
  • 1.3 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Region (Based on Production Site)
    • 1.3.1 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Value by Region (2021-2032)
    • 1.3.2 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Region (2021-2032)
    • 1.3.3 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Region (2021-2032)
    • 1.3.4 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (2021-2032)
    • 1.3.5 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (2021-2032)
    • 1.3.6 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (2021-2032)
  • 1.4 Market Drivers, Restraints and Trends
    • 1.4.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Drivers
    • 1.4.2 Factors Affecting Demand
    • 1.4.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Market Trends

2 Demand Summary

  • 2.1 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Demand (2021-2032)
  • 2.2 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Region
    • 2.2.1 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption by Region (2021-2026)
    • 2.2.2 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Forecast by Region (2027-2032)
  • 2.3 United States Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (2021-2032)
  • 2.4 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (2021-2032)
  • 2.5 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (2021-2032)
  • 2.6 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (2021-2032)
  • 2.7 South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (2021-2032)
  • 2.8 ASEAN Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (2021-2032)
  • 2.9 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption (2021-2032)

3 World Manufacturers Competitive Analysis

  • 3.1 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Value by Manufacturer (2021-2026)
  • 3.2 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Manufacturer (2021-2026)
  • 3.3 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Manufacturer (2021-2026)
  • 3.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Company Evaluation Quadrant
  • 3.5 Industry Rank and Concentration Rate (CR)
    • 3.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Rank of Major Manufacturers
    • 3.5.2 Global Concentration Ratios (CR4) for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in 2025
    • 3.5.3 Global Concentration Ratios (CR8) for Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in 2025
  • 3.6 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Overall Company Footprint Analysis
    • 3.6.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Region Footprint
    • 3.6.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Company Product Type Footprint
    • 3.6.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Company Product Application Footprint
  • 3.7 Competitive Environment
    • 3.7.1 Historical Structure of the Industry
    • 3.7.2 Barriers of Market Entry
    • 3.7.3 Factors of Competition
  • 3.8 New Entrant and Capacity Expansion Plans
  • 3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World

  • 4.1 United States VS China: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Value Comparison
    • 4.1.1 United States VS China: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Value Comparison (2021 & 2025 & 2032)
    • 4.1.2 United States VS China: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
  • 4.2 United States VS China: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Comparison
    • 4.2.1 United States VS China: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Comparison (2021 & 2025 & 2032)
    • 4.2.2 United States VS China: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Market Share Comparison (2021 & 2025 & 2032)
  • 4.3 United States VS China: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Comparison
    • 4.3.1 United States VS China: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Comparison (2021 & 2025 & 2032)
    • 4.3.2 United States VS China: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
  • 4.4 United States Based Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers and Market Share, 2021-2026
    • 4.4.1 United States Based Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers, Headquarters and Production Site (States, Country)
    • 4.4.2 United States Based Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Value (2021-2026)
    • 4.4.3 United States Based Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (2021-2026)
  • 4.5 China Based Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers and Market Share
    • 4.5.1 China Based Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
    • 4.5.2 China Based Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Value (2021-2026)
    • 4.5.3 China Based Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (2021-2026)
  • 4.6 Rest of World Based Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers and Market Share, 2021-2026
    • 4.6.1 Rest of World Based Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturers, Headquarters and Production Site (State, Country)
    • 4.6.2 Rest of World Based Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Value (2021-2026)
    • 4.6.3 Rest of World Based Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production (2021-2026)

5 Market Analysis by Type

  • 5.1 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Overview by Type: 2021 VS 2025 VS 2032
  • 5.2 Segment Introduction by Type
    • 5.2.1 XIFAXAN
    • 5.2.2 Viberzi
    • 5.2.3 Lotronex
    • 5.2.4 Other
  • 5.3 Market Segment by Type
    • 5.3.1 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Type (2021-2032)
    • 5.3.2 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Value by Type (2021-2032)
    • 5.3.3 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Type (2021-2032)

6 Market Analysis by Sales Channel

  • 6.1 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Overview by Sales Channel: 2021 VS 2025 VS 2032
  • 6.2 Segment Introduction by Sales Channel
    • 6.2.1 Hospitals Pharmacy
    • 6.2.2 Retail Pharmacy
    • 6.2.3 Other
  • 6.3 Market Segment by Sales Channel
    • 6.3.1 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Sales Channel (2021-2032)
    • 6.3.2 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Value by Sales Channel (2021-2032)
    • 6.3.3 World Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Sales Channel (2021-2032)

7 Company Profiles

  • 7.1 Bausch Health
    • 7.1.1 Bausch Health Details
    • 7.1.2 Bausch Health Major Business
    • 7.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services
    • 7.1.4 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.1.5 Bausch Health Recent Developments/Updates
    • 7.1.6 Bausch Health Competitive Strengths & Weaknesses
  • 7.2 Allergan
    • 7.2.1 Allergan Details
    • 7.2.2 Allergan Major Business
    • 7.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services
    • 7.2.4 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.2.5 Allergan Recent Developments/Updates
    • 7.2.6 Allergan Competitive Strengths & Weaknesses
  • 7.3 Sebela Pharmaceuticals
    • 7.3.1 Sebela Pharmaceuticals Details
    • 7.3.2 Sebela Pharmaceuticals Major Business
    • 7.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services
    • 7.3.4 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.3.5 Sebela Pharmaceuticals Recent Developments/Updates
    • 7.3.6 Sebela Pharmaceuticals Competitive Strengths & Weaknesses
  • 7.4 Astellas Pharmaceuticals
    • 7.4.1 Astellas Pharmaceuticals Details
    • 7.4.2 Astellas Pharmaceuticals Major Business
    • 7.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services
    • 7.4.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.4.5 Astellas Pharmaceuticals Recent Developments/Updates
    • 7.4.6 Astellas Pharmaceuticals Competitive Strengths & Weaknesses
  • 7.5 Amneal Pharms
    • 7.5.1 Amneal Pharms Details
    • 7.5.2 Amneal Pharms Major Business
    • 7.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services
    • 7.5.4 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.5.5 Amneal Pharms Recent Developments/Updates
    • 7.5.6 Amneal Pharms Competitive Strengths & Weaknesses
  • 7.6 Pharscin Pharma
    • 7.6.1 Pharscin Pharma Details
    • 7.6.2 Pharscin Pharma Major Business
    • 7.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product and Services
    • 7.6.4 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
    • 7.6.5 Pharscin Pharma Recent Developments/Updates
    • 7.6.6 Pharscin Pharma Competitive Strengths & Weaknesses

8 Industry Chain Analysis

  • 8.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Chain
  • 8.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Upstream Analysis
    • 8.2.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Core Raw Materials
    • 8.2.2 Main Manufacturers of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Core Raw Materials
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis
  • 8.5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Mode
  • 8.6 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Procurement Model
  • 8.7 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Sales Model and Sales Channels
    • 8.7.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Model
    • 8.7.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Typical Distributors

9 Research Findings and Conclusion

    10 Appendix

    • 10.1 Methodology
    • 10.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs. Industry analysis & Market Report on Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs is a syndicated market report, published as Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$4,480.00
    		$6,720.00
    		$8,960.00
    		3,463.04
    		5,194.56
    		6,926.08
    		4,170.88
    		6,256.32
    		8,341.76
    		684,051.20
    		1,026,076.80
    		1,368,102.40
    		378,112.00
    		567,168.00
    		756,224.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo